menu
    • menu

    Company profile for Veracyte

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Veracyte is a pioneering genomic diagnostics company. Our tests are dramatically improving clinical outcomes for patients by resolving inconclusive results from traditional diagnostic methods. We ask the right questions to resolve ambiguity and bring assurance to light, rendering tens of thousands of costly and unnecessary surgeries truly unnecessary. We are giving patients a clearer path forward.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VeracyteUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6000 Shoreline Court \nSuite 300 \nSouth San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.veracyte.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Veracyte To Participate In Upcoming Investor Conferences
    Veracyte To Participate In Upcoming Investor Conferences

    06 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251106918609/en/Veracyte-to-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    06 Nov 2025
    Share Share
    Veracyte Announces Third Quarter 2025 Financial Results
    Veracyte Announces Third Quarter 2025 Financial Results

    04 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251104771700/en/Veracyte-Announces-Third-Quarter-2025-Financial-Results

    BUSINESS WIRE
    04 Nov 2025
    Share Share
    Veracyte Introduces Afirma GRID For Advanced Thyroid Nodule
    Veracyte Introduces Afirma GRID For Advanced Thyroid Nodule

    03 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251103727651/en/Veracyte-Announces-First-Publications-Using-Afirma-GRID-Research-Tool-To-Help-Usher-in-Next-Generation-of-Thyroid-Nodule-Testing

    BUSINESSWIRE
    03 Nov 2025
    Share Share
    Veracyte To Unveil Q3 2025 Financial Results On Nov 4
    Veracyte To Unveil Q3 2025 Financial Results On Nov 4

    15 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251015446872/en/Veracyte-to-Release-Third-Quarter-2025-Financial-Results-on-November-4-2025

    BUSINESSWIRE
    15 Oct 2025
    Share Share
    Veracyte Biomarker Predicts Hormone Therapy Benefit In Cancer
    Veracyte Biomarker Predicts Hormone Therapy Benefit In Cancer

    28 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250928979637/en/Veracyte-Announces-that-Decipher-Enabled-Biomarker-Predicts-Hormone-Therapy-Benefit-in-Men-with-Recurrent-Prostate-Cancer

    BUSINESSWIRE
    28 Sep 2025
    Share Share
    Veracyte To Present Hormone Therapy Biomarker Validation Data
    Veracyte To Present Hormone Therapy Biomarker Validation Data

    24 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250924466091/en/Veracyte-Announces-First-Prospective-Validation-Data-for-Biomarker-Predicting-Hormone-Therapy-Benefit-in-Men-with-Recurrent-Prostate-Cancer-Will-Be-Presented-at-ASTRO-2025

    BUSINESSWIRE
    24 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search